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S U M M A R Y
Objective: To determine whether acid aspiration provokes the development of multidrug-resistant
Acinetobacter baumannii (MDRAB) pneumonia in its host.
Methods: Groups of mice were inoculated intratracheally (IT) with 50 ml of 0.1 N HCl and 1  108
colony-forming units (CFU) Ab396 (A + Ab group), or 50 ml of 0.1 N HCl and 20 ml of 0.9% saline (A + S
group), or 20 ml of 0.9% saline and 1  108 CFU of Ab396 (S + Ab group), or 50 ml of 0.9% saline and 20 ml
of 0.9% saline (S + S group). Cytokines, bacterial loads in the bronchoalveolar lavage ﬂuid (BALF), lung
permeability, histopathology of the lungs, and survival rates were evaluated.
Results: Only the A + Ab mice developed extensive Ab396 pneumonia and had signiﬁcantly elevated
bacterial loads, increased lung leakage, and lower levels of tumor necrosis factor alpha (TNF-a)
compared with the other three groups (p < 0.05, Mann–Whitney U-test). Moreover, a strong synergistic
effect (p < 0.05, two-way analysis of variance) was observed between the acid induction and Ab396
infection, resulting in lung injury and an unfavorable survival outcome.
Conclusions: Lung injury caused by acid aspiration provoked secondary MDRAB pneumonia; also
synergistic effects between acid aspiration and Ab396 infection resulted in a detrimental outcome in the
infected mice.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Acinetobacter baumannii is a non-fermenting Gram-negative
bacterium that is widely distributed in the natural environment.1 It
is also an important opportunistic pathogen in a variety of
nosocomial infections resistant to most current antibiotic thera-
pies.2,3 Nosocomial pneumonia caused by multidrug-resistant A.
baumannii (MDRAB) has been increasingly reported worldwide,4,5
resulting in high mortality rates (30–75%) in patients, particularly
those in hospital intensive care units.6,7 Several studies have
identiﬁed a number of risk factors for the occurrence of MDRAB
pneumonia, including tracheostomy, lasting ventilation, dialysis,
Stenotrophomonas maltophilia colonization, parenteral nutrition,* Corresponding author. Tel.: +886 6 2812811 ext. 26012; fax: +886 6 2833351.
E-mail address: chuangkenneth@hotmail.com (Y.-C. Chuang).
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http://dx.doi.org/10.1016/j.ijid.2013.01.022enteric feeding, and prior antimicrobial therapy.8–10 However, the
methodological heterogeneity of these studies makes it difﬁcult to
derive clear conclusions about the pathogenesis of MDRAB
pneumonia.
Gastric aspiration leads to a chemical burn with an intense
inﬂammatory reaction of the pulmonary parenchyma.11 It is
known to occur easily in unconscious, ventilated hospitalized
patients or in patients who have received general anesthesia.11–14
Moreover, a 6- to 21-fold increase in the incidence of pneumonia
after gastric aspiration in intubated patients has been reported.15
In fact, gastric aspiration can facilitate secondary bacterial
infection of the lungs and also lead to the development of acute
respiratory distress syndrome (ARDS).16
A. baumannii is considered an opportunistic pathogen. Never-
theless, a series of insults to a host may augment the host’s
immune response and lead to signiﬁcant lung injury.17,18 The
initial acid aspiration triggers a marked inﬂammatory response,ses. Published by Elsevier Ltd. All rights reserved.
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subsequent infectious challenge. Thus, we hypothesized that lung
injury after acid aspiration would provoke the development of
secondary MDRAB pneumonia in the host. To test this hypothesis,
we conducted a two-hit experimental design that combined the
well-established acid aspiration-induced model and a novel
secondary MDRAB infection protocol to determine whether prior
pulmonary acid aspiration is an important risk factor that
complicates MDRAB pneumonia.
2. Materials and methods
2.1. Microorganism
Ab396, an MDRAB strain that is only susceptible to colistin
methanesulfonate, was isolated from the bloodstream of a patient.
Aliquots were prepared and frozen at 80 8C until use. Details of
the minimum antibiotic inhibitory concentration of this strain are
presented in our previous report.19
2.2. Mice
Six- to eight-week-old inbred female BALB/c mice weighing 20–
22 g were purchased from the Animal Center of the National
Science Council, Taipei, Taiwan, for this study. Prior to the
experiments, the mice were allowed to adjust to the Animal
Center of Chi-Mei Medical Center for 5–7 days, with food and water
supplied ad libitum.19
2.3. Determination of the sub-lethal dose for the intratracheal (IT)
inoculum of Ab396
The median lethal dose (LD50) for Ab396 in mice was determined
to be 2.5  108CFU using previous methods.20To determine the sub-
lethal dose for this study, mice (n = 6 per group) were inoculated IT
with Ab396 concentrations of 1  109, 1  108, and 1  107 CFU in
20 ml 0.9% saline. Fatality rates on the third day were 100%, 0%, and
0%, respectively. Thus, a sub-lethal dose of 1.0  108 CFU of Ab396
per mouse was chosen for all subsequent experiments.
2.4. Establishment of lung injury after 0.1 N HCl instillation (the ﬁrst
hit)
The acute lung injury model induced by 0.1 N HCl was
performed as described previously.21 To ascertain that acute lung
injury was established, 12 mice were treated with IT 50 ml (2.5 ml/
kg) of 0.1 N HCl and six mice with 0.9% saline. The trachea was
cannulated with a 25-gauge needle and 1 ml 0.9% saline was
infused into the lungs; between 0.9 and 0.95 ml of BALF was
retrieved and the cells were immediately pelleted by centrifuga-
tion at 500 g for 5 min at 4 8C. Leukocyte concentrations, obtained
at 6 h after 0.1 N acid instillation, were determined by resuspend-
ing the cell pellets in 1 ml of phosphate-buffered saline (PBS, pH
7.2), using the Multisizer 3 Coulter Counter (Beckman Coulter). A
cytoslide was prepared with 5  104 leukocytes using a Cytospin 3
cytocentrifuge (Shandon, Pittsburgh, PA, USA) and stained with
Diff-Quik reagents (Baxter, Miami, FL, USA). The total and
differentiated cellular counts in BALF were assayed. Additionally,
six healthy mice without any treatment were enrolled as the
control group. The histopathology of the lungs was examined at
24 h in another four mice treated with 0.1 N HCl IT.
2.5. Experimental procedure for the two-hit Ab396 pneumonia model
A two-hit experiment was adapted from previous methods.19,21
Brieﬂy, mice were anesthetized with 70 mg/kg sodiumpentobarbital by intraperitoneal injection and supported on a
frame. The airway was externally illuminated by a lamp, and vocal
folds were exposed. A micropipette was passed down the pharynx,
and its tip was inserted between the vocal folds to administer the
ﬁrst hit of 50 ml 0.1 N HCl IT. After 5 min, the second hit of 1.0  108
CFU of Ab396 in 20 ml 0.9% saline (A + Ab group) or 20 ml 0.9% saline
only (A + S group) was delivered. A third group of mice was treated
with an initial IT challenge of 50 ml 0.9% saline, followed by IT
administration of 1.0  108CFU of Ab396 in 20 ml 0.9% saline (S + Ab
group) after the same 5-min time interval. Healthy mice given an
initial IT dose of 50 ml 0.9% saline, followed by IT administration of
20 ml 0.9% saline (S + S group), were enrolled as a control group.
2.6. Survival study
In the S + S, A + S, A + Ab, and S + Ab groups (n = 8 for each
group), the survival rates were recorded every day for 6 days after
the induction of secondary Ab396 pneumonia.
2.7. Bacterial loads and cytokine levels in BALF
Fifty treated mice in the S + S, A + S, S + Ab, and A + Ab groups
were tested. Brieﬂy, mice were anesthetized and the trachea
cannulated with a 25-gauge needle, as in our previous report.22
One milliliter of 0.9% saline was infused into the lungs. Between 0.9
and 0.95 ml BALF was retrieved from each mouse, and the cells
were immediately pelleted by centrifugation at 3500 g for 10 min
at 4 8C. Bacterial loads were measured in the BALF at 3, 6, 12, 24,
and 48 h after IT inoculation of Ab396, as previously reported.19
The cell-free supernatant was stored at 80 8C for analysis of
cytokine content. Levels of tumor necrosis factor alpha (TNF-a),
interleukin (IL)-6, macrophage inﬂammatory protein 2 (MIP-2),
and IL-10 in the BALF were assessed at the same time points as in
the previous report.22
2.8. Lung injury and interaction between the acidic environment and
the Ab396 infection in the lungs
Lung permeability was assayed to measure the lung injury in the
pneumonia model. The Evans blue dye (EBD) titer in the BALF was
assayed to determine lung permeability, as in our previous report.23
Brieﬂy, the trachea of each mouse was cannulated with a 25-gauge
needle. Evans blue dye (50 mg/kg) was administered via the tail vein
of the mouse, and 1 ml of 0.9% saline was infused into the lungs via
the tracheal needle. BALF was collected from the S + S, A + S, S + Ab,
and A + Ab mice at 6, 24, and 48 h (eight surviving mice were
collected and tested at each time point) for assay. The extravasated
EBD concentration in the BALF was calculated against a standard
curve to determine the change in lung permeability. Also, the
interaction effect between the acidic environment and the presence
of Ab396 on the permeability of the lungs from 6 to 48 h was assayed.
2.9. Histopathological study of the lungs
The lungs were harvested at 6, 12, 24, and 48 h after the second
hit from the mice in the A + Ab, A + S, and S + Ab groups, as well as
from the healthy mice (n = 4 for each time point). Tissues were
ﬁxed in 10% formaldehyde, embedded in parafﬁn, sectioned,
stained with hematoxylin–eosin (HE), and examined by light
microscopy. The micrographs of the HE-stained lung tissue were
reviewed by a pathologist.
2.10. Statistical analysis
The planned comparisons for the measured parameters (i.e., cell
counts in BALF, lung permeability, bacterial counts, and cytokine
Figure 1. Establishment of lung injury for the ﬁrst hit after 0.1 N HCl aspiration. (A) Total BALF cell counts, percent macrophages, and PMN levels in mice 6 h after intratracheal
injection of 0.1 N HCl or 0.9% saline, and in healthy controls. (B) Representative lung histology slide (hematoxylin and eosin stain) of the lungs from the mice at 24 h after 0.1 N
HCl instillation.
*Signiﬁcantly higher total cell numbers or percentage of PMN in the 0.1 N HCl group compared with the healthy control group.
#Signiﬁcantly higher total cell numbers or percentage of PMN in the 0.1 N HCl group compared with 0.9% saline group.
§Signiﬁcantly higher percentage of macrophages in the healthy control and 0.9% saline groups compared with the 0.1 N HCl group.
Figure 2. Survival rate of mice that were administered 0.1 N HCl intratracheally and
a sub-lethal dose (1.0  108 CFU) of Ab396 (A + Ab), 0.9% saline and 1.0  108 CFU
Ab396 (S + Ab), 0.1 N HCl and 0.9% saline (A + S), or 0.9% saline and 0.9% saline
(S + S) (n = 8 for each group) during 6 days of follow-up.
*Signiﬁcantly higher survival rates of the S + Ab, A + S, and S + S groups compared
with the A + Ab group.
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The interaction effect between acid and Ab396 on the lung injury
were explored by stratiﬁed analysis using the Mann–Whitney U-
test among the groups with Ab396 and without Ab396, respec-
tively. A full model of two-way analysis of variance (ANOVA) was
additionally performed to examine the statistical signiﬁcance of
the cross-product term of acid and Ab396. The mortality rates over
time were compared between the four groups using the log-rank
test. A p-value of less than 0.05 was considered statistically
signiﬁcant. Means are shown to describe the central tendency;
standard deviations to describe the data dispersion. All data were
analyzed with SPSS software (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Cellular analysis in BALF and histopathology of the lungs after IT
0.1 N HCl instillation
The total BALF cell counts in mice treated with 0.9% saline were
similar to those of the healthy control mice. However, 0.1 N HCl-
treated mice had a signiﬁcantly higher level of total BALF cell
numbers (4.0  1.12  106) than 0.9% saline-treated mice
(7.3  1.62  105) and healthy control mice (6.9  2.23  105) at
6 h after acid instillation (vs. 0.9% saline and healthy control mice, all
p < 0.05 by Mann–Whitney U-test). Moreover, a signiﬁcantly higher
percentage of polymorphonuclear leukocytes (PMN) (68.7  6.7%)
and lower percentage of macrophages (31.3  6.7%) were found in
0.1 N HCl-treated mice compared to the saline-treated mice (PMN
4.8  1.4%, macrophages 95.2  1.4%) and healthy control mice (PMN
2.5  1.3%, macrophages 97.5  1.3%) (vs. 0.9% saline, healthy mice
group, all p < 0.05 by Mann–Whitney U-test) (Figure 1A). Pathohis-
tologic ﬁndings in the lungs of mice at 24 h after 0.1 N HCl instillation
showed advanced protein-rich edema, capillary congestion, hemor-
rhage, and the presence of neutrophilic inﬁltrations and erythrocytes
in alveolar spaces (Figure 1B). These ﬁndings ascertained the
development of acute lung injury for the ﬁrst hit.
3.2. Survival study
The survival rates of mice in the S + S, A + S, S + Ab, and A + Ab
groups were 100%, 100%, 100%, and 0%, respectively, at 6 days(Figure 2). The survival rates of the S + S, A + S, and S + Ab groups
were signiﬁcantly higher than that of the A + Ab group (vs. A + Ab
group, all p < 0.05 by log-rank test).
3.3. Bacterial loads in BALF
There was an increase in the bacterial loads in A + Ab mice, from
3.13  108 CFU/ml at 3 h to 1.63  1010 CFU/ml at 24 h, after Ab396
inoculation (Figure 3). In contrast, while a high initial bacterial titer
of 4.73  107 CFU/ml was measured in the S + Ab mice at 3 h, there
was a progressive reduction to 1.3  103 CFU/ml, nearly equal to
that of the A + S and S + S mice, by 48 h. The bacterial titers of the
A + Ab group were signiﬁcantly higher than those of the S + S, A + S,
and S + AB groups at 3 to 24 h (vs. S + S, A + S, and S + Ab mice, all
p < 0.05 by Mann–Whitney U-test). The A + Ab mice suffered
severe mortality, and very few mice survived to allow assessments
beyond 48 h.
Figure 3. Time course analysis of bacterial loads of the BALF of mice that received
0.1 N HCl and 1.0  108 CFU of Ab396 (A + Ab), 0.9% saline and 0.9% saline (S+S),
0.9% saline and 1.0  108 CFU of Ab396 (S + Ab), or 0.1 HCl and 0.9% saline (A + S)
(n = 10); data are expressed as the mean  standard deviation.
*Signiﬁcantly higher bacterial loads compared with the S + S group.
#Signiﬁcantly higher bacterial loads compared with the A + S group.
§Signiﬁcantly higher bacterial loads compared with the S + Ab group.
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The A + Ab mice had signiﬁcantly lower levels of TNF-a than the
S + Ab mice from 3 to 12 h (Figure 4A) (vs. S + Ab group, all p < 0.05
by Mann–Whitney U-test). In contrast, the IL-6, MIP-2, and IL-10Figure 4. Cytokine proﬁles of (A) TNF-a, (B) IL-6, (C) MIP-2, and (D) IL-10 in BALF of mice t
CFU of Ab396 (S + Ab), 0.1 N HCl and 0.9% saline (A + S), or 0.9% saline and 0.9% saline (S +
in the four groups (n = 10); data are expressed as the mean  standard deviation.
ySigniﬁcantly higher TNF-a levels compared with the A + Ab group.
*Signiﬁcantly higher cytokine levels compared with the S + S group.
#Signiﬁcantly higher cytokine levels compared with the A + S group.
§Signiﬁcantly higher cytokine levels compared with the S + Ab group.levels in the A + Ab mice were signiﬁcantly higher than those in the
S + S, A + S, and S + Ab groups from 3 to 24 h after infection
(Figure 4, B–D) (vs. S + S, A + S, and S + Ab group, p < 0.05 for IL-6,
IL-10, and MIP-2, by Mann–Whitney U-test).
3.5. Lung permeability and the interaction between acid and Ab396
inoculation
Extensive lung permeability was found in the A + Ab mice.
There was a progressive increase in EBD titers in the A + Ab mice,
from 3020.6  934.1 mg/ml at 6 h to 10 875.9  4519.2 mg/ml at
48 h, after Ab396 inoculation (Figure 5). The lung permeability of the
A + Ab group was signiﬁcantly higher than those of the S + S, A + S,
and S + AB groups at 6, 24, and 48 h (vs. S + S, A + S, and A + Ab mice,
p < 0.05 by Mann–Whitney U-test).
The interaction between acid induction and Ab396 inoculation
for lung injury was also analyzed. At 6 h, a signiﬁcant difference
was found between the groups with and without acid treatment
(vs. without acid group, p < 0.05 at 6 h by Mann–Whitney U-test,
p-value of interaction < 0.05 at 6 h by two-way ANOVA),
regardless of the presence or absence of bacterial infection.
However, at 24 and 48 h, there was no signiﬁcant difference in the
lung permeability between the acid-treated and non-treated
groups in the absence of Ab396, but there was a signiﬁcant
difference in the presence of Ab396 (vs. without Ab396 group,
p < 0.05 at 24 and 48 h by the Mann–Whitney U-test, p-value of
interaction < 0.05 at 24 and 48 h by two-way ANOVA). This result
suggests a synergistic effect between acid environment and the
presence of bacteria on the permeability from 6 to 48 h after
treatment.hat received 0.1 N HCl and 1.0  108 CFU of Ab396 (A + Ab), 0.9% saline and 1.0  108
 S). Figures illustrate time-course analyses of the TNF-a, IL-6, MIP-2, and IL-10 levels
Figure 5. Time-course analysis of the lung permeability and the interaction
between the acidic environment and Ab396 infection in the mice that received
0.1 N HCl and 1.0  108 CFU of Ab396 (A + Ab), 0.9% saline and 1.0  108 CFU of
Ab396 (S + Ab), 0.1 N HCl and 0.9% saline (A + S), or 0.9% saline and 0.9% saline
(S + S) (n = 8 per group); data are expressed as the mean  standard deviation.
*Signiﬁcantly higher Evans blue levels compared with the S + S group.
#Signiﬁcantly higher Evans blue levels compared with the A + S group.
§Signiﬁcantly higher Evans blue levels compared with the S + Ab group.
ySigniﬁcantly higher Evans blue levels of the 0.1 N HCl or Ab396-treated groups
compared with the groups not given acid or Ab396 for the interaction study.
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The histopathology of the lungs of the tested mice is shown in
Figure 5. Mild inﬁltrations of polymorphonuclear leukocytes
(PMNs) into the pulmonary interstitium were observed in the
A + S (Figure 6A) and the S + Ab groups (Figure 6B). In contrast, the
infected lungs of the A + Ab group displayed advanced consolida-
tion, acute alveolar inﬂammation, and extensive inﬁltration ofFigure 6. Histopathologic changes of lungs in the mice that received (A) 0.1 N HCl and 0.9
1.0  108 CFU of Ab396 (A + Ab), sacriﬁced at 48 h post-infection, as well as (D) healthPMNs in the interstitium (Figure 6C). The intact alveolus with no
PMN inﬁltration from a healthy mouse is shown in Figure 6D.
4. Discussion
Our results demonstrate that 0.1 N acid aspiration directly
induces lung injury, and the ensuing interaction with Ab396 leads
to secondary pneumonia in mice. To our knowledge, this is the ﬁrst
study to investigate the causal association between acid aspiration
and the development of MDRAB pneumonia in vivo. These novel
ﬁndings may provide important insights into the pathogenesis and
prevention of MDRAB pneumonia.
The pathogenesis of secondary pneumonia after acid aspiration
has been investigated in previous experimental studies. Mitsush-
ima et al. infected mice with Pseudomonas aeruginosa 5 min after IT
delivery of 0.1 N HCl,21 but did not assess the inﬂammatory
responses of the lungs. Rotta et al. infected rats with Escherichia coli
1 min after IT gastric aspiration and reported transient increases in
TNF-a, IL-1b, and MIP-2, but a more sustained elevation of IL-10.24
Additionally, van Westerloo and colleagues infected mice with
Klebsiella pneumoniae 16 h after IT administration of 0.1 N HCl and
observed increased levels of TNF-a, IL-10, IL-6, MIP-2, and IL-1b.25
Our study differs from these earlier investigations, not only
because we used an opportunistic pathogen, but also because we
chose the 5-min time point for the bacterial challenge. Of note, we
also made an important novel observation of early down-
regulation of TNF-a levels in the BALF of mice with Ab396
pneumonia when compared with the S + Ab mice. These ﬁndings
demonstrate that Ab396 pneumonia following acid aspiration has
important immunological impacts on the host’s defense that differ
from the secondary pneumonia caused by other pathogens,25 in
addition to primary A. baumannii pneumonia in which increased
TNF-a expression has been reported.26
Our results demonstrate differences in the immunological
responses between the S + S, A + S, and S + Ab groups. Speciﬁcally,
the IL-10, MIP-2, and IL-6 levels were signiﬁcantly higher in the
A + Ab mice compared with the mice in the other three groups,
whereas the TNF-a levels were signiﬁcantly lower than those in% saline (A + S), (B) 0.9% saline and 1.0  108 CFU of Ab396 (S + Ab), (C) 0.1 N HCl and
y mice; hematoxylin and eosin stain.
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shift towards a weakened inﬂammatory response with lower TNF-
a levels and higher IL-10 levels in A + Ab mice compared with the
S + Ab mice.
TNF-a has a signiﬁcant role in the host’s innate pulmonary
defense against bacterial pathogens.27,28 Low levels of TNF-a in
the lungs may suggest impairment of the host’s antibacterial
responses. Moreover, excessive expression of IL-10 could lead to
less efﬁcient bacterial clearance, in part by a down-regulation of
TNF-a.29–31 Additionally, high IL-10 levels in BALF were strongly
correlated with lung injury and the inhibition of bacterial
clearance in pneumonia following acid aspiration.24,32 Thus,
low TNF-a and high IL-10 levels may contribute to the detrimental
outcome observed in the A + Ab mice, as demonstrated by a strong
correlation between high levels of anti-inﬂammatory mediators
and poor outcomes.33,34 In contrast, up-regulation of TNF-a has
been reported in animals following acid aspiration and secondary
pneumonia caused by other pathogens.25,35 However, the TNF-a
level may not necessarily equate to the severity of the
inﬂammatory reaction because anti-TNF-a therapy exhibits poor
efﬁcacy in the treatment of secondary pneumonia.25 Also, the
ﬁnding of up-regulation of MIP-2 levels is consistent with
previous reports,36 and this may play an important role in lung
injury after acid aspiration. Given the complexity of the immune
mechanisms responsible for protection against pathogens causing
secondary pneumonia, this immunopathogenesis requires further
investigation.
The precise pathogenesis of the deﬁcient TNF-a and high IL-10
responses in the A + Ab mice has not been fully explored. One
possibility is the up-regulation of receptor or signaling of toll-like
receptor 2 (TLR2) in vivo to decrease the TNF-a expression, as
Knapp et al. reported higher up-regulated TNF-a responses in
TLR2/ mice after infection with A. baumannii compared with
those in TLR4/ mice.26 Another possibility is that up-regulation
of IL-10 expression results in the attenuation of proinﬂammatory
cytokine levels to prevent systemic over-inﬂammation for the
immune system.29–31 It occurs in a condition of compensatory
anti-inﬂammatory response syndrome (CARS);37,38 in fact numer-
ous studies of ‘two-hit’ animal models have found a positive
correlation between the severity of CARS and poor outcomes in
secondary bacterial infections.37
It is important to note that without the initial lung permeability
induced by the preceding acid treatment, Ab396 inoculation alone
could not induce the extensive damaging effects observed in the
pneumonia. Thus, the initiation of lung injury by 0.1 N acid
aspiration is indispensable to provoke the secondary Ab396
pneumonia (Figure 5). Furthermore, neither the acid treatment
nor the Ab396 inoculation alone could establish the fatal effect
observed in the tested mice. Very little is known about the
interactions between A. baumannii infection and acid insult in lung
injury. Thus the interaction of the acidic environment and Ab396
infection was evaluated. These results illustrate that the joint effect
of the acidic environment and the presence of Ab396 exceeded the
sum of their individual effects in the causation of lung injury in
A + Ab mice (Figure 5). Therefore, a combination of acid plus Ab396
caused lung injury that was synergistically more severe than that
from either 0.1 N acid or Ab396 alone. This ﬁnding differs from
those of a previous report, in which only an acidic environment
contributed to lung injury due to E. coli pneumonia following
gastric aspiration.24 The link between preexisting acid aspiration
and the subsequent occurrence of MDRAB pneumonia merits
further evaluation.
In conclusion, our results highlight three major ﬁndings: (1)
lung injury induced by 0.1 N acid aspiration facilitates the
development of secondary Ab396 pneumonia; (2) weak TNF-a
expression in BALF may contribute to the decreased survival inA + Ab mice; and (3) the synergistic interaction between the acidic
environment and Ab396 infection enhanced the lung injury. These
data strongly support the hypothesis that acid aspiration is one of
multiple factors that can lead to secondary MDRAB pneumonia in
mice.
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